Objectives
After participating in this educational activity, attendees should be able to:
1| Describe the cefazolin inoculum effect and its importance in clinical practice
2| Assess the snap trial to evaluate cefazolin use for MSSA bacteremia
3| Apply current evidence to determine appropriate management of MSSA bacteremia
Presenter(s):
Gianna DeNoto, PharmD
Gianna DeNoto, PharmD
PGY1 Pharmacy Resident
Baystate Medical Center
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
| Gianna DeNoto, PharmD | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Session date:
10/19/2026 - 2:30pm to 3:00pm EDT
Location:
Hybrid
United States
See map: Google Maps
Add to calendar:
- 0.50 ACPE Contact Hours
- 0.50 ACPE Technician contact hours
Facebook
X
LinkedIn
Forward